PWC
ABBV icon

PYA Waltman Capital’s AbbVie ABBV Stock Holding History

PYA Waltman Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.61M Buy
21,203
+597
+3% +$132K 1.28% 17
2025
Q4 		$4.71M Sell
20,606
-220
-1% -$50.1K 1.27% 16
2025
Q3 		$4.82M Buy
20,826
+451
+2% +$91.8K 1.29% 17
2025
Q2 		$3.78M Buy
20,375
+1,871
+10% +$348K 1.09% 22
2025
Q1 		$3.88M Buy
18,504
+51
+0.3% +$9.91K 1.22% 18
2024
Q4 		$3.28M Buy
18,453
+402
+2% +$73.9K 1.06% 23
2024
Q3 		$3.56M Buy
18,051
+846
+5% +$158K 1.16% 22
2024
Q2 		$2.95M Buy
17,205
+1,117
+7% +$185K 1.08% 24
2024
Q1 		$2.93M Buy
16,088
+282
+2% +$48.6K 1.09% 20
2023
Q4 		$2.45M Buy
15,806
+1,939
+14% +$283K 1.02% 23
2023
Q3 		$2.07M Buy
13,867
+3,106
+29% +$456K 0.88% 24
2023
Q2 		$1.64M Buy
10,761
+2,869
+36% +$421K 0.71% 24
2023
Q1 		$1.26M Buy
7,892
+2,454
+45% +$375K 0.62% 24
2022
Q4 		$879K Buy
5,438
+934
+21% +$143K 0.46% 25
2022
Q3 		$604K Buy
4,504
+2,556
+131% +$367K 0.35% 27
2022
Q2 		$298K Buy
1,948
+646
+50% +$98.7K 0.17% 34
2022
Q1 		$211K Buy
1,302
+550
+73% +$79.9K 0.1% 43
2021
Q4 		$102K Buy
+752
New +$88.8K 0.05% 68

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

PYA Waltman Capital's ABBV Position: Q1 2026 in Review

PYA Waltman Capital increased its AbbVie (ABBV) stake by 2.9% in Q1 2026, buying an estimated $132K and bringing the position to 21,203 shares worth $4.61M. The position accounts for 1.28% of the portfolio, ranked #17.

PYA Waltman Capital first reported a position in ABBV in Q4 2021 and has held it in 18 quarters since. The position peaked at $4.82M in Q3 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • PYA Waltman Capital held 21,203 shares of AbbVie worth $4.61M as of Q1 2026.
  • PYA Waltman Capital bought 597 AbbVie shares in Q1 2026, an estimated $132K.
  • AbbVie made up 1.28% of PYA Waltman Capital's portfolio in Q1 2026, its #17 holding.
  • PYA Waltman Capital first reported a position in AbbVie in Q4 2021 and has held it in 18 quarters since.
  • PYA Waltman Capital's AbbVie position peaked at $4.82M in Q3 2025.
  • 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on PYA Waltman Capital's 13F filing for Q1 2026, filed 13 May 2026.